Ms. O’Farrell joined the PDL BioPharma Board of Directors in June 2018. Ms. O’Farrell previously served 24 years with Eli Lilly and Company, most recently as Chief Procurement Officer from 2012 to 2017.
At Eli Lilly, Ms. O’Farrell advanced through various executive management positions, including Senior Vice President, Policy and Finance; Senior Vice President, Finance; Chief Financial Officer, Lilly USA; Chief Financial Officer, Lilly Canada; and General Auditor. Before joining Eli Lilly, Ms. O’Farrell was an accountant with Boise Cascade Office Products and auditor at Whipple & Company and Price Waterhouse. Ms. O’Farrell holds a B.S. in accounting with honors and an MBA in management information systems, both from Indiana University.
Ms. O’Farrell currently serves on the Board of Directors of Geron Corporation and served as a Board member of the YMCA of Greater Indianapolis for more than a decade and as its Chair from 2014 to 2016. She is a member of the Finance Committee of the United Way of Brevard in Brevard County, FL., and previously served on the Boards of the Washington Township Schools Foundation and Keep Indianapolis Beautiful.
Ms. O’Farrell brings to the PDL Board of Directors extensive experience as a senior executive of a major pharmaceutical company with global operations. In addition to her role as Chairperson of the PDL BioPharma Board of Directors, she is Chair of the Compensation Committee and a member of the Audit Committee.